BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment
North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin […]
BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment Read More »
Translate






